Objectives This study investigates the prognostic value of PSMA and [18F]FDG-PET in metastatic castration-resistant prostate cancer (mCRPC) patients considered for LuPSMA therapy. FDG-PET total tumor volume (FDG-VOL) was an independent predictor of ...
Markdown supported · ⌘↵ to post
No responses yet.